Aims: The aim of this study was to develop a new class of gallium (Ga)-doped chitosan (CS) coatings fabricated by electrophoretic deposition (EPD) in staphylococcal infection therapy. Methods and Results: Biofilm formation on EPD CS/Ga coatings by Staphylococcus epidermidis and Staphylococcus aureus, which are the main strains involved in postarthroplasty infections, was assessed. The codeposition of an antibacterial agent was effective; Ga loaded into CS matrix reduces biofilm viability by up to 86% and 80% for S. epidermidis and S. aureus strains respectively. Lastly, the influence of pulsed electromagnetic field (PEMF) on the bactericidal activity of CS/Ga coatings was investigated in vitro. To this end, the coatings were incubated with S. epidermidis and S. aureus and exposed to the PEMF using two different frequencies and times. Biofilm viability for S. epidermidis was decreased by 35-40% in the presence of lowfrequency (LF) and high-frequency (HF) PEMF respectively. Biofilm viability by S. aureus was not further reduced in the presence of LF PEMF, but decreased by 38% at HF PEMF. Conclusions: This study has established that a combination of PEMFs with the antibacterial agent improves bactericidal activity of Ga against S. epidermidis strain 14990 and S. aureus strain 12600. Significance and Impact of the Study: This new integrated approach could reduce the incidence of infection in orthopaedic implant applications. It also clearly demonstrates that the combination of Ga treatment with PEMF could aid biofilm-associated infection therapy due to improved Ga efficiency.
Introduction
Infections after orthopaedic surgery have increased over the recent years despite the use of antibiotics and more refined surgical techniques (Bozic and Ries 2005; Kurtz et al. 2008) . As the demand for orthopaedic surgery increases with the ageing population, the number of infection cases will pass 266 000 per year in the United States by 2030 (Bozic and Ries 2005; Kurtz et al. 2007a Kurtz et al. , 2007b Kurtz et al. , 2008 . Bacteria (especially staphylococci) form extracellular biofilms on implanted metallic/plastic materials, block the penetration of immune cells and antibiotics, result in their survival (Darouiche 2004; Zimmerli et al. 2004; Trampuz and Widmer 2006; Del Pozo and Patel 2009 ). The surgical removal of all the implanted materials is necessary after biofilm formation. Around 70% of these kinds of infections are caused by the staphylococcal species (Fulkerson et al. 2006; Salgado et al. 2007; Walls et al. 2008) . The pharmacological treatment of postarthroplasty infection is difficult due to bacteria resistant to antibiotics such as methicillin-resistant Staphylococcus aureus (MRSA) (Darouiche 2004; Zimmerli et al. 2004; Trampuz and Widmer 2006; Pulido et al. 2008; Del Pozo and Patel 2009) .
The conventional treatment for postarthroplasty infection usually involves a two-stage procedure; first, surgical removal of all prosthetic components and placement of an antibiotic-impregnated spacer, and second, revision arthroplasty after the infection has been cleared (Jiranek et al. 2006; Cui et al. 2007; Mittal et al. 2007; Diwanji et al. 2008; Chiu and Lin 2009; Toulson et al. 2009 ). Together with patient discomfort, these additional procedures can result in additional medical costs. All these issues have necessitated the prevention of infection (Campoccia et al. 2006; Hetrick and Schoenfisch 2006; Zhao et al. 2009) .
As a novel method to tackle this issue, we designed chitosan (CS)/gallium (Ga) composite coating to be applied to implant surfaces, prepared by electrophoretic deposition (EPD). EPD is a deposition technique with different advantages such as cost-effectiveness, versatility in materials that can be processed, reasonable control over the thickness of the coatings and a high level of homogeneity in terms of microstructure (Besra and Liu 2007) . CS is a cationic polysaccharide biopolymer for tissue engineering, as it is a biocompatible coating capable of drug delivery (Simchi et al. 2009 ). According to the particular CS properties, such as biodegradability, biocompatibility, nontoxicity, it is one of the most interesting materials for tissue engineering ranging from skin, bone, cartilage and vascular grafts as substrates for cell culture and drug-delivery systems (Malafaya et al. 2007) . Previous studies have shown the feasibility of cationic EPD of CS (Varoni et al. 2016) .
Ga(III) can be potentially used as an antibacterial agent. As Ga 3+ is similar to Fe 3+ in radius, electronegativity, charge and coordination number (da Silva et al. 2009; Franchini et al. 2012) , it can substitute the iron in its process and act as a "Trojan horse" against bacteria, such as Pseudomonas aeruginosa and Staphylococcus epidermidis (Kaneko et al. 2007; Rzhepishevska et al. 2011) . Ga is sequestered by the bacteria through their iron uptake systems, by the siderophores. Once inside, the metal blocks the iron-dependent process where there is crucial oxidation of iron (Fe 2+ to Fe 3+ ) because Ga(III) cannot be reduced to give continuity to sequential oxidation and reduction (da Silva et al. 2009 ). Ga(III) blocks osteoclast resorption by preventing attachment to the surface of the bone without appearing to be cytotoxic to osteoclasts, or by inhibiting cellular metabolism (Rimondini et al. 2013; Cochis et al. 2016) .
In this work, after studying the morphology of the coatings and finding the optimum conditions for uniform coating, the release profile of Ga in different concentrations was studied, as Ga results in bactericidal activity. We assessed biofilm formation and cell growth in the presence of the composite-coated surfaces by S. epidermidis and S. aureus, both Gram-positive bacteria, which are the two main strains that cause postarthroplasty infections (Campoccia et al. 2006; Del Pozo and Patel 2009; Lv et al. 2014) . For this reason, this work studied the antibacterial activity of EPD of CS/Ga composite coatings against Gram-positive bacteria.
The EPD of CS/Ga coating on orthopaedic implants shows excellent bactericidal activity as well as biocompatible properties. Furthermore, the polymer-antibacterial agent (Ga) implant coating evaluated in this study was effective, suggesting the potential for this strategy as a therapeutic intervention to combat postarthroplasty infections. This novel coating could reduce the incidence of infection in orthopaedic implant applications.
Finally, the in vitro influence of PEMF on the modification of bactericidal activity of the CS/Ga composite coatings is investigated. The therapeutic efficacy for the stimulation of bone growth with PEMFs is already proven in controlled double-blind studies (Sharrard 1990; Linovitz et al. 2002; Simonis et al. 2003; Griffin et al. 2008) . Using PEMF, we observed a further decrease in biofilm viability up to 40% for S. epidermidis and 38% for S. aureus compared to Ga treatment alone.
Materials and methods

Materials
CS (deacetylated chitin, poly(D-glucosamine), medium molecular weight, Lot#STBG1894V), Gallium(III) nitrate hydrate (crystalline, 99Á9% trace metals basis, Lot#MK BQ1999V), acetic acid (99Á7%), Dulbecco's phosphate-buffered saline (Lot#RNBG5989), lysozyme from chicken egg white (Lot#SLBX2243) and water (CHROMASOLVâ Plus, for HPLC) were all supplied by Sigma-Aldrich (Milan, Italy) and used without further purification. To evaluate the in vitro biological response, human primary osteogenic sarcoma cell line SAOS-2 (ECACC 89050205) was used.
Trypticase soy broth (TSB) (30 g l À1 in purified water, autoclave at 121°C for 15 min; Becton, Dickinson and Company, Los Angeles, CA) was used for the routine growth of bacterial cells, crystal violet stain was used to quantify biofilm viability (0Á41% w/v in ethanol and DI water; Fisher Scientific Company, Los Angeles, CA) and Wash Buffer was used to change the medium of the bacterial cells (Hamon and Lazazzera 2002) . Staphylococcus epidermidis strain 14990 and S. aureus strain 12600 both from the American Type Culture Collection were used in the study. cell (Fig. 1) . Processing conditions have been optimized in order to achieve a uniform, homogeneous and consistent deposition of coatings; Square waves (75-100 V, duty cycle = 0Á17) have been used in the water-based bath (pH = 3Á67, (CS) = 1 g l À1 , (Gallium(III) nitrate hydrate) = 10 mg l À1 (LGa) and (Gallium(III) nitrate hydrate) = 100 mg l À1 (HGa)). In vitro degradation The degradation study was performed by immersing the specimens in phosphate buffered saline (PBS) (pH 7Á4) at 37°C containing 1Á5 lg ml À1 lysozyme (from chicken egg white). The lysozyme concentration was selected according to the concentration in human serum (Brouwer et al. 1984; Porstmann et al. 1989) . The dried scaffolds were cut into small circle specimens (D = 7 mm) and weighed (dry weight). At different time points (up to 3 days), specimens were removed from the solution and carefully dried at 37°C in an oven overnight. The specimens were weighted to measure the weight loss:
Microstructural characterization
where w t is the weight of the dry specimen at different time points and w o is the weight of the dry specimen before immersing in lysozyme solution.
Antibacterial agent (Ga) release study The in vitro release of Ga from the EPD CS matrix was studied by incubating composite coating (20 mm 9 20 mm 9 0Á2 mm) in 7Á5 ml of PBS (Sigma-Aldrich P4417-50TB) at 37°C. Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES; Perkin Elmer Optima 2000DV OES) analysis was used to investigate the release of the antibacterial agent. To determine the release of Ga from the CS matrix, three specimens for each treatment at each time point (1, 2, 4, 8, 14, 24 h and 3, 7 days) were incubated in PBS. They were fixed vertically in 15-ml falcon tubes with a conical end, to allow release of the antibacterial agent from both sides of the specimen. The tubes were maintained at 37°C in a thermostatic oven under constant gentle shaking (75 rev min À1 ) (VDRL DIGITAL MOD.
711/D). Aliquots of PBS from three specimens were analysed by ICP-OES to determine the concentration of Ga released. The PBS solution was also analysed by ICP-OES to standardize the data.
Biological and microbiological characterization
Cytotoxicity tests on extract For cytotoxicity assessment, sample eluates were obtained, according to UNI EN ISO 10993-5, by incubating the samples in a culture medium for 24 h. Cell culture medium was prepared using McCoy's 5a medium, with 15% foetal bovine serum,
penicillin/streptomycin. The extraction ratio (sample surface area/eluate volume) was 3 cm 2 ml À1 . SAOS-2 cells were seeded at a density of 10 4 cells cm À2 in a 96-well microtitre plate and cultured with a complete medium until 70% confluency for 24 h was achieved. The medium was then replaced with eluates or control (i.e. 24-h-old medium) and cells were returned to the incubator. After 24 h, Alamar Blue TM assay (BioReagent, Sigma-Aldrich R7017) was performed to evaluate cell viability. Plate fluorescence (530 nm EX /590 nm Em ) was spectrophotometrically read (Genios Plus plate reader; Tecan, Milan, Italy) to evaluate possible cytotoxic effects associated with the tested material.
Crystal violet assay and colony-forming unit counting To evaluate biofilm viability by S. epidermidis and S. aureus, crystal violet assay was performed. One millilitre of diluted (1 : 100) overnight culture of S. epidermidis in TSB was added to each sample in each well of the 24-well, flat bottom microtitre plate. All the coatings were autoclaved (Tuttnauer cat2007, Los Angeles, CA) for 1 h at 150°C to be sterilized. The plate was incubated under static conditions at 37°C for 24 h. The growth media was removed, and the wells washed three times with 1 ml Wash Buffer. At the next step, 1 ml of crystal violet was added to each well and incubated at room temperature for 15 min. Crystal violet was removed, and the wells were washed twice with 1 ml of distilled water and 1 ml of an 80% ethanol, 20% acetone solution was added. To allow the biofilm to detach from the coating surface, the coating containing biofilms was resuspended in 1 ml of TSB, vortexed and sonicated at 60 Hz (Aquasonic 250HT; VWR International, Los Angeles, CA) for 30 s; this was repeated five times. The suspension was used to prepare six 10-fold dilutions. A 100 ll volume of each dilution was spotted onto Lysogeny broth (LB) plates and incubated for 24 h at 37°C. The following day, the number of CFUs ml À1 was counted, under blinded conditions, and using the following formula (Kuhn et al. 2003; Harrison et al. 2006; Rivardo et al. 2009 ):
Biofilm morphology
To study the morphology of a biofilm which was formed by S. epidermidis on the CS/Ga coatings, a variable-pressure scanning electron microscope (VP-SEM) (Zeiss supra 40VP) was used. To study the morphology of biofilm, the samples were washed three times in de-ionized water and dried at 37°C in an oven for 1 h.
Pulsed electromagnetic field
To investigate the in vitro effect of a PEMF on the efficacy of an antibacterial agent (Ga) in the treatment of coated orthopaedic implant infection, two different frequencies, 40 850 Hz as the high frequency (HF) and 3846 Hz as the low frequency (LF), were used to expose the specimens to the PEMF. PEMF was applied for 15 min and 4 h to the coatings which were incubated into S. epidermidis strain 14990 and S. aureus strain 12600, respectively, in a 24-well microtitre rack. The rack was located in the incubator. The Dial-A-Stim IV in vitro system was used to generate PEMF for the experiments. The in vitro system used to generate PEMF consists of a polycarbonate rack that can be placed inside an incubator, a custom-made signal control box, an arbitrary waveform generator and a timer. The treatment rack is shown in Fig. 2 . The system is able to provide both LF and HF PEMF (HF = 40Á850 kHz pulse frequency and magnetic field amplitude of 1Á2 mT; LF = 3Á846 kHz, burst period of and magnetic field amplitude of 0Á7 mT). A square waveform profile with a burst period of 70 ms was applied.
Statistical data analysis
All results are reported as mean AE SD. Significant differences between the two sets of data were determined by oneway ANOVA followed by Tukey post hoc test for pairwise comparisons and P < 0Á05 was considered statistically significant. The Statistical Package for the Social Sciences was used for the calculations (Minitab Express TM Version 1.4.0, Milan, Italy). Figure 3 shows the SEM images of (a) pure CS and (b, c) CS/Ga composite coating with different Ga concentrations ((Gallium(III) nitrate hydrate) = 10 and 100 mg l À1 ): a porous structure in pure CS coating is evident. Ga-doped coatings show a different morphology and a homogeneous presence of bright spots. Energy-dispersive X-ray (EDX) analysis allows the identification of such clusters, mainly deposited on the pore borders (Fig. 3d,e) . The EDX spectrum (Fig. 3f,g ) contains peaks associated with Ga atoms. Before studying the Ga release rate, the total amount of Ga loaded into the CS matrix during EPD was determined as a function of Ga content in the suspension by ICP-OES analysis (Fig. 4a) . As seen, the efficiency during EPD was approximately 66-55% which is quite acceptable (Fig. 4a) (Data S1).
Treatment rack
Results
Feasibility of EPD CS/Ga composite coating
The release of Ga from the CS matrix, measured by ICP-EOS, occurred during the first 7 days. The released Ga was detected in 7Á5 ml of PBS with a maximum of 0Á0137 and 0Á0013 mg cm À2 from high Ga concentration ((Gallium(III) nitrate hydrate) = 100 mg l À1 ) and low Ga concentration ((Gallium(III) nitrate hydrate) = 10 mg l À1 ) deposition baths respectively (Fig. 4b) .
To evaluate whether the release rate is controlled by the degradation of the CS matrix in the PBS solution over a long incubation period, the cumulative weight loss of the CS coating in PBS was also determined (Fig. 4c) . As can be observed, the amount of CS weight loss in PBS was noticeable only after a long period of incubation. Figure 5 summarizes the biodegradation results. An increasing weight loss was observed for CS and CS/Ga composite coatings over a course of time. The CS sample showed 34Á2% degradation within 3 days. This number is 21Á4% and 19Á8% for CS/LGa and CS/HGa composite structure respectively.
Degradation
Cytotoxicity assessment and bactericidal activity
Cytotoxicity test on extracts Figure 6 shows the results of cell viability for SAOS-2 cells cultured with pure (100%) or diluted (50% and 10% in fresh medium) eluates from CS and CS/Ga composite coatings. No evidence of cytotoxicity was detected in any of the examined samples. The cell viability (%) vs control was 109Á76%, 107Á77% and 96Á05% for CS, CS/LGa and CS/HGa composite coatings respectively.
Biofilm viability
Figures 7(a) and 8(a) summarize the biofilm viability results assayed by the crystal violet method on S. epidermidis strain 14990 and S. aureus strain 12600, cultured in TSB medium. After 24 h, all Ga-doped specimens differed significantly from untreated pure CS coating (P < 0Á05, Figs 7 and 8, indicated by *) resulting in a significant bacterial inhibition. For S. epidermidis, both CS/ LGa and CS/HGa coatings caused a reduction in biofilm viability of about 15 and 60%, respectively, after 24 h, and a reduction of 82 and 86%, respectively, after 3 days (Fig. 7a) . For S. aureus, both CS/LGa and CS/HGa coatings caused a reduction in biofilm viability of about 10 and 55%, respectively, after 24 h, and a reduction of 40 and 80%, respectively, after 3 days (Fig. 8a ) due to increasing Ga release which is consistent with the degradation study (Fig. 5 ). An increasing weight loss was observed for CS and CS/Ga composite coatings over a course of time. As a consequence, the release of entrapped Ga from the CS matrix was increasing.
This assay was repeated with TSB media adjusted to different pH values; regardless of the pH medium, the CS/Ga coating exhibited a reduced number of viable bacterial cells (Figs 7b and 8b) .
The effect of the CS/Ga composite coating on the cell viability of S. epidermidis was measured as the total CFU present in the planktonic phase of the cultures incubated with the coatings (Fig. 9) . The composite coating with a high Ga concentration (HGa) gave the lowest number of planktonic CFU, yielding 8Á3% and 4Á5% of the population on untreated CS after 24 h and 3 days respectively. The effect of the CS/Ga composite coating on the viability of cells in the biofilm phase of the culture was measured as the total CFU presence in the medium after the detachment of the cells from the surface. The coatings with highest Ga concentration resulted in the lowest CFU, yielding 27 and 37% of the population on untreated CS for S. epidermidis strain 14990 and S. aureus strain 12600 respectively (Fig. 10) .
Biofilm morphology
At different Ga concentrations, colonies were found attached on the surface of the coating specimen after 24 h incubation. These results were substantiated by the VP-SEM images (Figs 11 and 12) . The SEM micrographs revealed reduced biofilm formation by S. epidermidis and S. aureus grown on CS/Ga composite coatings compared with the pure CS control (Figs 11a  and 12a ). The biofilm formed on Ga were poorly structured, very thin, arrested at the microcolony stage and had reduced surface area coverage. It is also evident that the biofilm structure on the CS/HGa composite coating (Figs 11c and 12c) is only a single-layer of cells when compared to the CS/LGa composite structure biofilm (Figs 11b and 12b) .
PEMF effect on bactericidal activity of the coatings
Four separate experimental setups were used to expose coatings incubated in bacterial cultures of S. epidermidis and S. aureus in the TSB media to (i) a low-frequency PEMF, 3846 Hz for 15 min and 4 h and (ii) a high- Each of the four applied fields showed a biofilm viability reduction of S. epidermidis and S. aureus in the presence of Ga within 24 h of the experiment (Figs 13 and 14) . The best results were obtained by LF for 4 h in both strains. Exposure to a PEMF increased the effectiveness of Ga against the 1-day biofilms of S. epidermidis and S. aureus.
Discussion
After fabricating CS/Ga composite coating by EPD, its feasibility was confirmed by X-ray map and EDX spectrum techniques and due to hydrolysis of water during EPD process (Varoni et al. 2016 ), a porous structure in pure CS is evident. Ga appears to be distributed mainly on the pore borders, probably due to the higher current density in such areaa (Lanzi 1990; Zhitomirsky and Galor 1997; Besra and Liu 2007) . From the EDX analysis, a difference is evident in the relative peak of Ga according to the different bath concentrations. EDX analysis performed on CS/Ga substrates proved the presence of gallium (Fig. 3f,g ), the ICP-OES investigation as well detected the Ga release from the prepared materials (Fig. 4a) . This result highlights that gallium could be physically bound to CS macromolecules (e.g. weak bonds) or entrapped into the CS macromolecules (Data S2, Fig. S1 ).
The degradation of CS has already been studied carefully before (Pangburn et al. 1982; Lee et al. 1995; Tomihata and Ikada 1997; V arum et al. 1997) . In general, polysaccharides are degraded by enzymatic hydrolysis. It is well established that, in human serum, CS is depolymerized enzymatically by lysozyme (V arum et al. 1997) . The enzyme hydrolyses the glycosidic bonds of polysaccharide which results in biodegradation. Lysozyme contains a hexameric binding site (Pangburn et al. 1982) , and hexasaccharide chains containing acetylated units lead to the initial degradation of the CS and CS/Ga composite coatings (Nordtveit et al. 1994) . The critical period to inhibit biofilm formation after the implantation surgery is 6 h (Zilberman and Elsner 2008) . However, even for a longer term, certain species of adhered bacteria are capable of forming a biofilm at the implant-tissue interface (Hetrick and Schoenfisch 2006; Zilberman and Elsner 2008; Simchi et al. 2011) . Therefore, we performed the drug release studies for an extended time period. Two release phases can be highlighted. In the early phase, a burst of release was observed (after 2 h). A second phase follows, in which very little additional release was detected. Significant CS weight loss was observed only after a long period of incubation in PBS (Ordikhani et al. 2014) , suggesting that water molecules destroy the hydrogen bond among CS fibres, disordering the macromolecule alignments that may lead to dissolution/degradation. As a prerequisite, the cytotoxicity assessment suggests that the prepared composite coatings are not toxic to human osteoblast-like cells in good agreement with previous studies .
To evaluate the bactericidal activity of CS/Ga coatings, different aspects should be considered. First of all, CS inherently shows remarkable antibacterial activity against a broad spectrum of bacteria due to the interaction between positively charged CS and negatively charged microbial cell wall, which leads to the leakage of intracellular constituents (Aimin et al. 1999; Kim et al. 2008) . Another phenomenon that should be considered is pHresponsive swelling behaviour of CS which makes CS to be a proper matrix for the controlled release of pharmaceuticals (Aimin et al. 1999) . In the following section, the biofilm viability assay in different pHs on S. epidermidis strain 14990 and S. aureus strain 12600 is discussed. Generally, the pH drops in the presence of bacteria (Bernthal et al. 2010) . CS matrix was confirmed to release Ga both passively and actively, in response to lowering pH. At a lower pH, the amide groups on the CS can become protonated, forming the hydrophilic NH the buffer solution can diffuse into the network easily which would facilitate the equilibrium swelling ratios to increase. According to the swelling, the diffusion rate increases from the matrix to the exterior. As a consequence, the embedded agents in the matrix will be released easier and faster (Zou et al. 2015) . Besides affecting planktonic bacteria, Ga seems to be efficient to reduce biofilm cells (Fig. 10) . Consequently, Ga can be effective against either planktonic or biofilm cells. Gallium is metabolically very similar to Fe 3+ , acting as an iron substitute in several biological pathways. With respect to its chemical similarity to Fe 3+ in terms of charge, ionic radius, electronic configuration and coordination number, Ga can substitute iron in siderophoredependent biological systems; this capability underlies its antibacterial action. Since Ga 3+ cannot be reduced under the same conditions as Fe 3+ , sequential redox reactions critical for the biological functions by Fe 3+ are impaired when iron is replaced: Ga thus inhibits Fe 3+ by a "Trojan horse" strategy (Kaneko et al. 2007; Garc ıa-Contreras et al. 2014; Modarresi et al. 2015) .
As previously mentioned, the therapeutic efficacy for the stimulation of bone growth with pulsating electromagnetic fields (PEMF) is already proven. Recently, enhancing the eradication of biofilms in the clinical infection of implants is being viewed with more interest. For the first time, Khoury et al. (1992) demonstrated that antibiotic efficacy would be increased against biofilm bacteria in the presence of a very week electric field.
Growth inhibition of S. aureus induced by low-frequency electric and electromagnetic fields is also reported by Obermeier et al. (2009) .
The PEMF resulted in a further decrease in biofilm viability up to 40% for S. epidermidis and 38% for S. aureus compared to the Ga treatment alone.
However, reactive oxygen and nitrogen species were not measured in the medium after magnetic treatment; according to the PEMF effect on bactericidal activity of the obtained CS/Ga coatings results, hydroxyl and oxygen radicals are known to destroy cell membranes of bacteria and may be present with the application of an electromagnetic field. This is the so-called bioelectric effect (Benson et al. 1994; Costerton et al. 1994; McLeod et al. 1999; Pickering et al. 2003) . This may facilitate the penetration of antibacterial agents into the biofilm and subsequently into the cells and could be an explanation for the detected modification of Ga efficacy. In this study, we have demonstrated that a combination of PEMFs with the antibacterial agent, improves bactericidal activity of Ga against S. epidermidis strain 14990 and S. aureus strain 12600. We conclude that the combination of Ga treatment with low-frequency PEMF could promise new opportunities in biofilm-associated infection therapy due to the improved Ga efficiency.
Taken together, an animal model could be potentially be used to provide important information about in vivo clinical efficacy of preclinical preventative or therapeutic modalities against post-arthroplasty infections before more extensive studies in human subjects. Furthermore, the therapeutic efficacy of Ga under the used fields should be proven in well-designed, evidence-based, randomized clinical studies in the future. PEMF can be developed into a device that can be applied externally to patients. This novel modification could result in an application of lower antibiotic concentrations leading to a decrease of side effects.
